05.04.2017 : A novel bio-synthetic Extra Cellular Matrix Technology Platform is leading the way in bio-printing


A novel bio-synthetic Extra Cellular Matrix Technology Platform is leading the way in bio-printing

regenHU Ltd., an innovative bio-printing solution provider, has combined its expertise with PeptiGelDesign Technologies to provide a range of synthetic ready-to-use bio-inks specifically designed for bio-printing in 3D cell biology and tissue engineering applications.

Bio-inks are fluid-like materials which encapsulate bio-actives (living cells, proteins) which can be 3D printed into bio-architectures (e.g.  custom-designed implants or tissue constructs) for drug testing. While numerous bio-inks are already obtainable, no viable solution for in-vivo relevant models were currently available.

Consequently we are very proud to announce that we can now offer an innovative series of ready-to-print synthetic hydrogels. Based on the understanding of the self-assembling behaviour of small peptides in water, the EMC-Bioink™ hydrogels are non-Newtonian materials which display shear thinning properties while providing a 3-dimensional peptide nanofiber scaffold that promotes both cell growth and migration.

Allowing a tight control of the mechanical strength, as well as cell-scaffold interaction, the EMC-Bioink™ family will enable researchers to produce structures that closely resemble the complex architecture and function of real tissue. Used as either a stand-alone matrix or embedded in a component system, these synthetic extracellular matrices can be used in a wide range of situations: to study tissue or disease, drug discovery, efficacy and toxicity or in the creation of regenerative implants.

Both revolutionary and cutting edge EMC-Bioink™ is available in five variations. If you wish to know more and observe the advantages of these unique bio-inks you will find more detailed information on our website:

About regenHU Ltd.
regenHU is an innovative biomedical company based in Switzerland. regenHU acts as a bio-systems architect, developing new bio-manufacturing solutions in response to the emerging challenges facing the biomedical industry and regenHU’s confirmed cutting-edge solutions are currently being implemented globally. regenHU benefits from exclusive patented technologies resulting from many years of research and development in collaboration with international universities and industrial partners.

About PeptiGelDesign Technologies Ltd.
PeptiGelDesign Technologies’ (PGDt)  vision is to be at the core of regenerative medicine solutions. Experts in synthetic biomaterials, the PGDt  team has engineered scalable life-changing solutions in answer to presently unmet needs in the fields of Life Science and Biomedical applications. The company, based in Cheshire, UK, have developed a family of customisable self-assembling peptide-based synthetic extra cellular matrices systems that perfectly mimic the cell microenvironment. Being both reproducible and animal free products, these systems are entirely compatible with liquid handling processes and biological system interrogation techniques. PT provides user and cell friendly synthetic ECMs for 3D cell culturing as well as for Bio-printing.

Together we are Shaping the Future of Healthcare
Here are a few examples of our partners achievements:




Freigeist Fellowship supports Dr. Ivan Minev in using 3D printing to find ways to repair damage in the human body.


Trinity College Dublin

Scientists in Ireland have developed a process to make new bones using 3D bioprinting technology.

Trinity College Dublin
UMC Utrecht, Regenerative Medicine Center

UMC Utrecht, Regenerative Medicine Center

UMC Utrecht and regenHU to develop new bioprinting technology.


Tel Aviv University

3D bioprinting bionic heart patches

 Tel Aviv University
 IBEC, Institute for Bioengineering of Catalonia

IBEC, Institute for Bioengineering of Catalonia

3D Bioprinting : a step closer to bespoke body parts


14.11.2016 : émission TTC, RTS Swiss Television

Dr. Ivan Minev, research group leader at the BIOTEC/CRTD, has been awarded a Freigeist Fellowship from the VolkswagenStiftung. This five-year, 920.000 EUR grant will enable him to establish his own research team. The ‘Freigeist’ initiative is directed toward enthusiastic scientists and scholars with an outstanding record that are given the opportunity to enjoy maximum freedom in their early scientific career.

02.09.2016 : Trinity College Dublin

"Scientists in Ireland have developed a process to make new bones using 3D bioprinting technology.
The development could lead to new methods for large and complex defects in bones to be repaired - replacing the need for bone grafts.
More than two million people globally need a bone graft each year to repair problems caused by conditions like tumour removal, infection, injury and inherited deformities.
Grafts usually involve taking bone from the patient's body, or from a donor, but they can be painful, and can lead to complications at the donor and graft sites."

30.09.2016 : Press Release

UTRECHT, 8 July 2016 -- Partnering experts in 3D bioprinting with experts in biomanufacturing has resulted in the first melt electrospinning device that incorporates the use of bio-inks. Housed at the Utrecht Biofabrication Facility, this combination of techniques may lead to improved and more accurate 3D bioprinting for therapeutic use.